[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349483-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349483-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","arginine-deprivation-of-ass1-deficient-cancers-drives-mistranslation-and-shared-neoepitope-production","Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production","","Arginine biosynthesis is commonly suppressed in ASS1-deficient cancers due to loss of ASS1 activity, making tumor cells dependent on extracellular arginine. Systemic arginine-depleting strategies are clinically safe yet limited in benefit. This study shows that under arginine scarcity, low-ASS1 cancer cells shift to aberrant mRNA translation, including ribosomal frameshifts and amino acid misincorporations. Proteomics and immunopeptidomics confirm endogenous aberrant protein production, and TCR-T cells recognize the resulting HLA-presented mistranslated peptides and efficiently kill cancer cells after deprivation, supporting improved therapeutic combinations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/arginine-deprivation-of-ass1-deficient-cancers-drives-mistranslation-and-shared-neoepitope-production/349483/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/arginine-deprivation-of-ass1-deficient-cancers-drives-mistranslation-and-shared-neoepitope-production/349483.png","ImageObject",300,407,{"name":42,"@type":43},"Guten tag","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are ASS1-deficient cancer cells reliant on extracellular arginine?","Question",{"text":63,"@type":64},"Loss of argininosuccinate synthase 1 (ASS1) suppresses arginine biosynthesis, preventing de novo arginine production and forcing dependence on extracellular arginine supplies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What translational changes occur during arginine scarcity in low-ASS1 cancer cells?",{"text":68,"@type":64},"Arginine deprivation triggers aberrant mRNA translation, characterized by ribosomal frameshifts and amino acid misincorporations, with a predominant effect at AGA codons.",{"name":70,"@type":61,"acceptedAnswer":71},"How do the generated neoepitopes enable T-cell killing?",{"text":72,"@type":64},"The mistranslated peptides are presented on HLA molecules, and TCR T cells that specifically recognize them efficiently kill cancer cells following arginine deprivation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349483,1790872374,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production  \nRemco Nagel1, Adva Kochavi1, Karine Flem-Karlsen2,3, Mrittika Adhikary1, Yali Gal-On1,  \nMaria G. Klaoudatou1, Julien Champagne1, Lorenzo Valcanover1, Heyilimu Palashati2,3, Morten M. Nielsen2,3, Xiaodong Feng1, Pierre-Rene Krner1, Lisanne Giebel1, Weiwen Yang2,3, Arno Velds4, Liesbeth Hoekman5, Onno B. Bleijerveld5, Olaf van Tellingen6, Johanna Olweus2,3, and Reuven Agami1,7  \nABSTRACT  \nArginine biosynthesis is frequently suppressed in cancer be- Significance: Aberrant protein production induced by arcause of the loss of argininosuccinate synthase 1 (ASS1) ex- ginine deprivation in ASS1-low cancers leads to production of pression, rendering cancer cells reliant on extracellular arginine. neoantigens that represent promising targets for TCR-T cell This feature has driven the development of systemic arginine- therapies.  \ndepleting strategies, which are clinically safe but offer limited clinical benefit. In this study, we demonstrated that under arginine scarcity, cancer cells with low ASS1 expression resort to aberrant mRNA translation, characterized by ribosomal frameshifts and amino acid misincorporations. Although aberrant proteins originated from most arginine codons, the predominant effect was observed at AGA. This codon preference was caused by a selective decrease in tRNAArg (UCU) levels following arginine deprivation, linked to methyltransferase-like  \n1 (METTL1)–mediated tRNA modification. Proteomics and immunopeptidomics analyses validated that arginine shortage induced aberrant protein production at the endogenous level.  \nT-cell receptor (TCR) T cells that specifically recognize these HLA-presented mistranslated peptides efficiently killed cancer cells after arginine deprivation. These results lay the foundation for improved cancer therapies by combining systemic argininedepleting strategies with TCR-based targeting of nonclassical neoantigens.  \n􀀶  \nIntroduction  \nAn integral characteristic of cancer cells is their ability to rewire cellular metabolism, which is now recognized as a hallmark of cancer. These metabolic adaptations are believed to confer a selective advantage under hypoxia and nutrient scarcity in the tumor microenvironment (1) . Given the large variety of oncogenes and tumor suppressors that influence various metabolic processes, it is surprising that these alterations often converge on shared metabolic programs sustaining a proliferative phenotype (2) .  \n1Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. 2Department of Cancer Immunology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. 3Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway. 4NKI Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. 5NKI Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. 6Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. 7Erasmus MC, Rotterdam University, Rotterdam, the Netherlands.  \nR. Nagel and A. Kochavi contributed equally to this article as co-first authors.  \nK. Flem-Karlsen and M. Adhikary contributed equally to this article as cosecond authors.  \nAn example of a common cancer-specific metabolic adaptation is the deregulation of the urea cycle (Fig. 1A; ref. 3). This metabolic route is involved in the clearance of excess ammonia by a multistep conversion of the amino acid aspartate to arginine (4). Intriguingly, alterations in the expression of various enzymes in the urea cycle have been observed in a wide range of cancers, of which suppression of argininosuccinate synthase 1 (ASS1) expression is most prominent (5). Dysregulation of the urea cycle fuels pyrimidine production, which supports cellular proliferation and tumorigenesis (3, 6). Although these alterations confer  \nCorresponding Authors: Reuven Agami, The Netherlands C","cbCaitb8OMDCnDGn","https://ap.wps.com/l/cbCaitb8OMDCnDGn","pdf",4114170,22,"English","# Abstract\n# Introduction\n## Urea cycle and ASS1 suppression in cancer metabolism\n## Targetable neoepitopes after arginine deprivation\n# Figure 1: Arginine shortage and codon-biased ribosome stalling","[{\"question\":\"Why are ASS1-deficient cancer cells reliant on extracellular arginine?\",\"answer\":\"Loss of argininosuccinate synthase 1 (ASS1) suppresses arginine biosynthesis, preventing de novo arginine production and forcing dependence on extracellular arginine supplies.\"},{\"question\":\"What translational changes occur during arginine scarcity in low-ASS1 cancer cells?\",\"answer\":\"Arginine deprivation triggers aberrant mRNA translation, characterized by ribosomal frameshifts and amino acid misincorporations, with a predominant effect at AGA codons.\"},{\"question\":\"How do the generated neoepitopes enable T-cell killing?\",\"answer\":\"The mistranslated peptides are presented on HLA molecules, and TCR T cells that specifically recognize them efficiently kill cancer cells following arginine deprivation.\"}]","Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production | PDF",1790083501,55,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7c9bb663574c09ea5701674751f59b2.webp",983,1315,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b320cba1312d88cd04156ae7edde65b3.webp",982,1314,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3ac2e50edd54330b95b79cc241ee290.webp",981,1312,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da51d713245364b7dcca908fc949d90f.webp",980,1311]